Using AI to spot lung disease

Israel’s Medial EarlySign (see here previously) has partnered US-based Geisinger to identify patients at high risk for respiratory or pulmonary diseases such as lung cancer. Their LungFlag AlgoMarker analyzes data from a patient’s electronic health record to enable early screening.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *